المؤلفون: Céleste Lebbé, Lars Bastholt, Aimilios Lallas, Judit Oláh, Piotr Rutkowski, A. Zhukavets, V. Todorovic, Nicole W.J. Kelleners-Smeets, Ricardo Vieira, A.M. Forsea, Claus Garbe, Catherine A. Harwood, J.-J. Grob, M. Bylaite-Buckinskiene, J. Ocvirk, M. Banjin, Alexandros Stratigos, Reinhard Dummer, K. Putnik, David Moreno-Ramírez, Lidija Kandolf-Sekulović, Raimonds Karls, Valerie Vandersleyen, Georg Weinlich, John Paoli, P. Arenberger, Axel Hauschild, Helen Gogas, Mirna Šitum, Ketty Peris, Christoph Hoeller, A. Ymeri

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Dermatologie, MUMC+: MA Dermatologie (9)

المصدر: Journal of the European Academy of Dermatology and Venereology, 35(5), 1119-1132. Wiley
Kandolf-Sekulovic, L, Peris, K, Stratigos, A, Hauschild, A, Forsea, A-M, Lebbe, C, Lallas, A, Grob, J-J, Harwood, C, Gogas, H, Rutkowski, P, Olah, J, Kelleners-Smeets, N W J, Paoli, J, Dummer, R, Moreno-Ramirez, D, Bastholt, L, Putnik, K, Karls, R, Hoeller, C, Vandersleyen, V, Vieira, R, Arenberger, P, Bylaite-Buckinskiene, M, Ocvirk, J, Situm, M, Weinlich, G, Banjin, M, Todorovic, V, Ymeri, A, Zhukavets, A & Garbe, C 2021, ' Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries ', Journal of the European Academy of Dermatology and Venereology, vol. 35, no. 5, pp. 1119-1132 . https://doi.org/10.1111/jdv.17086Test

مصطلحات موضوعية: medicine.medical_specialty, melanom, liječenje, profesije, Sentinel lymph node, Dermatology, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Surveys and Questionnaires, Care pathway, medicine, melanoma, Humans, Melanoma, Dermatoscopy, medicine.diagnostic_test, Medical treatment, business.industry, Incidence, Incidence (epidemiology), Cancer, medicine.disease, Europe, Infectious Diseases, 030220 oncology & carcinogenesis, Family medicine, Health Expenditures, Skin cancer, business, Settore MED/35 - MALATTIE CUTANEE E VENEREE

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f8f725bec92bbad0a507a4945097c7Test
https://cris.maastrichtuniversity.nl/en/publications/a0a50f7f-740c-42af-81ca-a839360edb9aTest

المؤلفون: J. Ocvirk, Bart Neyns, Ketty Peris, Matilda Bylaite-Bucinskiene, Gabriela Cinat, A.M. Forsea, Claus Garbe, A. Wainstein, Lars Bastholt, Reinhard Dummer, A. Zhukavets, Grant A. McArthur, V. Todorovic, Céleste Lebbé, K. Putnik, M. Alvarez, Petr Arenberger, M. Kukushkina, L. Kandolf Sekulovic, C. Gorry, Jun Guo, Alexandros Stratigos, Axel Hauschild, Christian Caglevic, N. Babovic, I. Stojkovski, M. Banjin, Christoph Hoeller, A. Ymeri, L. De La Cruz Merino, Richard Duncombe, Paul Lorigan, Helen Gogas, K. Kirov, Sanjiv S. Agarwala, Piotr Rutkowski, Ricardo Vieira, D. Herceg

المساهمون: Clinical sciences, Medical Oncology, Laboratory for Medical and Molecular Oncology, Laboratory of Molecullar and Cellular Therapy

المصدر: Kandolf Sekulovic, L, Guo, J, Agarwala, S, Hauschild, A, McArthur, G, Cinat, G, Wainstein, A, Caglevic, C, Lorigan, P, Gogas, H, Alvarez, M, Duncombe, R, Lebbe, C, Peris, K, Rutkowski, P, Stratigos, A, Forsea, A M, De La Cruz Merino, L, Kukushkina, M, Dummer, R, Hoeller, C, Gorry, C, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Arenberger, P, Bylaite-Bucinskiene, M, Babovic, N, Banjin, M, Putnik, K, Todorovic, V, Kirov, K, Ocvirk, J, Zhukavets, A, Ymeri, A, Stojkovski, I & Garbe, C 2018, ' Access to innovative medicines for metastatic melanoma worldwide : Melanoma World Society and European Association of Dermato-oncology survey in 34 countries ', European Journal of Cancer, vol. 104, pp. 201-209 . https://doi.org/10.1016/j.ejca.2018.09.013Test

مصطلحات موضوعية: Oncology, Compassionate Use Trials, Cancer Research, Market access, Innovative medicines, Russia, Targeted therapy, 0302 clinical medicine, access, Surveys and Questionnaires, Market price, Per capita, METASTATIC MELANOMA, 030212 general & internal medicine, Melanoma, Reimbursement, health care economics and organizations, Clinical Trials as Topic, Access, Immunooncology, Metastatic melanoma, Treatment, Health technology, targeted therapy, Europe, Value-Based Purchasing, 030220 oncology & carcinogenesis, Scale (social sciences), Practice Guidelines as Topic, oncology, Guideline Adherence, Settore MED/35 - MALATTIE CUTANEE E VENEREE, medicine.medical_specialty, Gross Domestic Product, Human Development, Drug Costs, Reimbursement Mechanisms, 03 medical and health sciences, Internal medicine, medicine, Humans, Health policy, business.industry, Health Priorities, Prescription Fees, Drugs, Investigational, medicine.disease, Latin America, Socioeconomic Factors, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f58b955fc2570105dc2a792abec6e9fTest
https://hdl.handle.net/20.500.14017/147fc775-7a3d-445a-b0b2-78b4193aa8bfTest

المؤلفون: Velda Smajlbegović, Amina Jalovčić, M. Banjin

المصدر: Okrugli sto s međunarodnim učešćem "Melanom".

مصطلحات موضوعية: business.industry, Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::761841948b41d8c3ccd86ec8cda001eaTest
https://doi.org/10.5644/pi2019.180.02Test

المؤلفون: Ketty Peris, Lev V. Demidov, Lars Bastholt, J.-J. Grob, Paul Nathan, M. Banjin, M. Kukushkina, Alexandros Stratigos, A.M. Forsea, A. Ymeri, Matilda Bylaite-Bucinskiene, Christoph Hoeller, A. Zhukavets, V. Todorovic, G. Weinlich, Claus Garbe, K. Putnik, L. Kandolf Sekulovic, Piotr Rutkowski, M. Risteski, K. Kirov, Iris Zalaudek, J. Ocvirk, Reinhard Dummer, D. Herceg, J. Maric-Brozic, Helen Gogas, Ricardo Vieira, Judit Oláh, Ivana Krajsová, N. Babovic, L. De La Cruz Merino, C. Blank, Johan Hansson, Bart Neyns, Axel Hauschild, C. Lebbé

المساهمون: Laboratory of Molecullar and Cellular Therapy, Laboratory for Medical and Molecular Oncology, Clinical sciences, [Sekulovic, L. Kandolf] Mil Med Acad, Fac Med, Dept Dermatol, Belgrade, Serbia, [Peris, K.] Univ Cattolica Sacro Cuore, Inst Dermatol, Rome, Italy, [Hauschild, A.] Univ Hosp Schleswig Holstein UKSH, Dept Dermatol, Campus Kiel, Kiel, Germany, [Stratigos, A.] Univ Athens, Athens, Greece, [Gogas, H.] Univ Athens, Athens, Greece, [Grob, J. -J.] Hop la Timone, Serv Dermatol & Cancerol Cutanee, Marseille, France, [Nathan, P.] Mt Vernon Canc Ctr, Northwood, Middx, England, [Dummer, R.] Univ Hosp, Univ Spital Zurich, Skin Canc Ctr, Zurich, Switzerland, [Forsea, A. -M.] Carol Davila Univ Med & Pharm, Elias Univ Hosp Bucharest, Bucharest, Romania, [Hoeller, C.] Med Univ Vienna, Dept Dermatol, Vienna, Austria, [Demidov, L.] NN Blokhin Russian Canc Res Ctr, Moscow, Russia, [Lebbe, C.] Hosp St Louis, APHP, Paris, France, [Blank, C.] Netherland Canc Inst, Amsterdam, Netherlands, [Olah, J.] Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary, [Bastholt, L.] Odense Univ Hosp, Dept Oncol, Odense, Denmark, [Herceg, D.] Univ Hosp Zagreb, Dept Oncol, Zagreb, Croatia, [Neyns, B.] VUB, Univ Ziekenhuis Brussel, Dept Med Oncol, Brussels, Belgium, [Vieira, R.] Univ Coimbra, Fac Med, Dept Dermatol, Coimbra, Portugal, [Hansson, J.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden, [Hansson, J.] Karolinska Univ Hosp Solna, Stockholm, Sweden, [Rutkowski, P.] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland, [Rutkowski, P.] Inst Oncol, Warsaw, Poland, [Krajsova, I.] Gen Teaching Hosp, Prague, Czech Republic, [Bylaite-Bucinskiene, M.] Vilnius Univ, Dept Dermatol, Vilnius, Lithuania, [Zalaudek, I.] Med Univ Graz, Div Dermatol & Venerol, Graz, Austria, [Maric-Brozic, J.] Univ Hosp Ctr Sestre Milosrdnice, Zagreb, Croatia, [Babovic, N.] Inst Oncol & Radiol Serbia, Belgrade, Serbia, [Banjin, M.] Univ Hosp Sarajevo, Dept Oncol, Sarajevo, Bosnia & Herceg, [Putnik, K.] North Estonia Med Ctr, Tallinn, Estonia, [Weinlich, G.] Med Univ Innsbruck, Dept Dermatol & Venerol & Allergy, Innsbruck, Austria, [Todorovic, V.] Clin Oncol & Radiotherapy, Podgorica, Montenegro, [Kirov, K.] Natl Canc Ctr, Clin Oncodermatol, Sofia, Bulgaria, [Ocvirk, J.] Inst Oncol Ljubljana, Ljubljana, Slovenia, [Zhukavets, A.] NN Alexandrov Natl Canc Ctr Belarus NCCB, Minsk, BELARUS, [Kukushkina, M.] Natl Canc Inst, Kiev, Ukraine, [De La Cruz Merino, L.] Hosp Univ Virgen Macarena, Dept Clin Oncol, Seville, Spain, [Ymeri, A.] Univ Hosp Mother Theresa, Tirana, Albania, [Risteski, M.] Univ Clin Radiotherapy & Oncol, Skopje, Macedonia, [Garbe, C.] Eberhard Karls Univ Tubingen, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany, Kandolf Sekulovic, L., Peris, K., Hauschild, A., Stratigos, A., Grob, J. -J., Nathan, P., Dummer, R., Forsea, A. -M., Hoeller, C., Gogas, H., Demidov, L., Lebbe, C., Blank, C., Olah, J., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Hansson, J., Rutkowski, P., Krajsova, I., Bylaite-Bucinskiene, M., Zalaudek, I., Maric-Brozic, J., Babovic, N., Banjin, M., Putnik, K., Weinlich, G., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Kukushkina, M., De La Cruz Merino, L., Ymeri, A., Risteski, M., Garbe, C.

المصدر: Kandolf Sekulovic, L, Peris, K, Hauschild, A, Stratigos, A, Grob, J J, Nathan, P, Dummer, R, Forsea, A M, Hoeller, C, Gogas, H, Demidov, L, Lebbe, C, Blank, C, Olah, J, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Hansson, J, Rutkowski, P, Krajsova, I, Bylaite-Bucinskiene, M, Zalaudek, I, Maric-Brozic, J, Babovic, N, Banjin, M, Putnik, K, Weinlich, G, Todorovic, V, Kirov, G K, Ocvirk, J, Zhukavets, A, Kukushkina, M, De La Cruz Merino, L, Ymeri, A, Risteski, M & Garbe, C 2017, ' More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments ', European Journal of Cancer, vol. 75, pp. 313-322 . https://doi.org/10.1016/j.ejca.2017.01.012Test

مصطلحات موضوعية: Human development index, Male, Cancer Research, Skin Neoplasms, Survival, medicine.medical_treatment, Access, Health expenditure per capita, Immunooncology, Innovative medicines, Metastatic melanoma, Targeted therapy, Treatment, Acrylonitrile, Aniline Compounds, Antibodies, Monoclonal, Humanized, Europe, Female, Health Services Accessibility, Healthcare Disparities, Humans, Immunotherapy, Melanoma, Programmed Cell Death 1 Receptor, Proto-Oncogene Proteins B-raf, Reimbursement Mechanisms, Therapies, Investigational, Oncology, Investigational, Reimbursement Mechanism, Melanoma/economics, Disparities, Immuno oncology, Medicines, 0302 clinical medicine, Diagnosis, Health care, Monoclonal, 030212 general & internal medicine, Healthcare Disparities/economics, Acce, Acrylonitrile/analogs & derivatives, Humanized, Proto-Oncogene Proteins B-raf/antagonists & inhibitors, Reimbursement, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Aniline Compound, Healthcare Disparitie, Health Services Accessibility/economics, 030220 oncology & carcinogenesis, Targeted therapy Health, Innovative medicine, Health-care, Settore MED/35 - MALATTIE CUTANEE E VENEREE, Treatment Immunooncology, Human, medicine.medical_specialty, Reimbursement Mechanisms/statistics & numerical data, Union, Antibodies, Europe/epidemiology, Malignant-melanoma, 03 medical and health sciences, Pharmacotherapy, Internal medicine, medicine, Skin Neoplasm, Human Development Index, Mortality, Therapies, Investigational/economics, Skin Neoplasms/economics, Health policy, business.industry, Cancer, medicine.disease, access, innovative medicines, metastatic melanoma, treatment, immunooncologytargeted therapyhealth expenditure per capita, human development index, Surgery, Immunotherapy/economics, Therapies, Aniline Compounds/economics, Skin cancer, business, Cancer incidence, Antibodies, Monoclonal, Humanized/economics

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f963ef44b2ff1f7ae62a81d631ae3c4Test
https://portal.findresearcher.sdu.dk/da/publications/08a9e901-9c2e-4d58-beae-d673d2edee93Test

المؤلفون: Lars Bastholt, C. Caglevich, Grant A. McArthur, Bart Neyns, D. Herceg, A. Wainstein, A. Zhukavets, Reinhard Dummer, L. Kandolf Sekulovic, Helen Gogas, Jun Guo, Paul Lorigan, Piotr Rutkowski, Axel Hauschild, M. Banjin, Gabriela Cinat, Claus Garbe, J. Ocvirk, Sanjiv S. Agarwala, C. Lebbé

المصدر: Kandolf Sekulovic, L, Agarwala, S, Hauschild, A, Guo, J, McArthur, G A, Lorigan, P, Cinat, G, Caglevich, C, Lebbe, C, Rutkowski, P, Gogas, H, Dummer, R, Neyns, B, Bastholt, L, Wainstein, A, Herceg, D, Banjin, M, Zhukavets, A, Ocvirk, J & Garbe, C 2018, ' Major determinants of delayed access to innovative medicines for metastatic melanoma: The results of Melanoma World Society and European Association of Dermato-Oncology survey ', Annals of Oncology, vol. 29, no. Suppl. 8, pp. viii563 . https://doi.org/10.1093/annonc/mdy297.004Test

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Metastatic melanoma, business.industry, Internal medicine, Melanoma, Medicine, Hematology, business, medicine.disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e340fd56a6e574a8132f0046ce40dca5Test
https://doi.org/10.1093/annonc/mdy297.004Test

المؤلفون: Semir Beslija, Azra Rasic, Timur Ceric, M. Banjin, A. Djuran, Elma Kapisazovic, Anes Pasic, A. Jalovcic, Irmina Sefić-Pašić, Berisa Hasanbegovic

المصدر: Annals of Oncology. 26:iv55

مصطلحات موضوعية: Oncology, chemistry.chemical_classification, medicine.medical_specialty, biology, Colorectal cancer, business.industry, Topoisomerase, Hematology, medicine.disease, Irinotecan, Enzyme, chemistry, Internal medicine, medicine, biology.protein, In patient, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a1e7917774c3363e0f97aa6bb98a9b1cTest
https://doi.org/10.1093/annonc/mdv233.187Test

المؤلفون: Semir Beslija, E. Ajanovic, B. Salkic, Anes Pasic, M. Banjin, N. Obralic, L. Tinjic, S. Jungic, I. Rakita, G. Kecman-Malcic

المصدر: European Journal of Cancer Supplements. 5:256-257

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, business.industry, Colorectal cancer, Phases of clinical research, medicine.disease, Capecitabine/irinotecan, First line therapy, Internal medicine, medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9bb9e3dcba39577154cd07ca284bb5cdTest
https://doi.org/10.1016/s1359-6349Test(07)70996-5

المؤلفون: G. Kecman-Malcic, N. Obralic, Semir Beslija, V. Smoljanovic, M. Banjin, B. Salkic, L. Tinjic, I. Rakita, S. Jungic, Anes Pasic

المصدر: Journal of Clinical Oncology. 27:e15064-e15064

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, Colorectal cancer, business.industry, Phases of clinical research, Cancer, medicine.disease, Surgery, Irinotecan, Capecitabine, First line therapy, Internal medicine, medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1ca4fea430390f4fdc48c4c9c0cffc47Test
https://doi.org/10.1200/jco.2009.27.15_suppl.e15064Test

المؤلفون: B. Salkic, M. Banjin, N. Obralic, S. Jungic, Anes Pasic, L. Tinjic, I. Rakita, G. Kecman-Malcic, Semir Beslija, E. Ajanovic

المصدر: Journal of Clinical Oncology. 25:14502-14502

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, Colorectal cancer, business.industry, Phases of clinical research, Cancer, medicine.disease, Capecitabine, Irinotecan, First line therapy, Internal medicine, medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::65758c4e9d86878e104f4ab02c19e72bTest
https://doi.org/10.1200/jco.2007.25.18_suppl.14502Test

المؤلفون: A. Sosevic, M. Naila, Semir Beslija, A. Tatarevic, Timur Ceric, M. Banjin, H. Basic, A. Cardzic, Anes Pasic, N. Obralic, B. Salkic

المصدر: Journal of Clinical Oncology. 24:571-571

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Time to progression, business.industry, medicine.disease, Metastatic breast cancer, law.invention, Capecitabine, First line therapy, Randomized controlled trial, Docetaxel, law, Internal medicine, Overall survival, medicine, business, Sequence (medicine), medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7954dc44351af6e8da5a771b821ede9dTest
https://doi.org/10.1200/jco.2006.24.18_suppl.571Test